00078-0669
Arzerra
Ofatumumab
INJECTION, SOLUTION
Intravenous
Ofatumumab
20.0
mg/mL
00078-0669-13
3 VIAL, SINGLE-USE in 1 CARTON (0078-0669-13) > 5 mL in 1 VIAL, SINGLE-USE (0078-0669-61)
Feb. 1, 2016

00078-0669-61
Feb. 1, 2016

00078-0669-84
Feb. 1, 2016
Feb. 1, 2016
Immunotherapy
Monoclonal Antibody
CD20
 
 
In Use